✦ LIBER ✦

Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients

✍ Scribed by Michele Malaguarnera; Marco Vacante; Rosangela Fichera; Alessandro Cappellani; Erika Cristaldi; Massimo Motta

Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 214 KB
Volume: 51
Category: Article
ISSN: 0167-4943
DOI: 10.1016/j.archger.2009.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum transforming growth factor α level

Serum transforming growth factor α level as a marker of hepatocellular carcinoma complicating cirrhosis

✍ Tomoaki Tomiya; Kenji Fujiwara 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 1 views

Transforming growth factor u (TGFn) is alleged to play a role in malignant progression as well as normal cell growth in an autocrine manner and its serum levels have been reported to increase during this progression. Most hepatocellular carcinomas (HCC) develop in cirrhotic livers in which hepatocyt

Serum concentration of intercellular adh

Serum concentration of intercellular adhesion molecule–1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis

✍ Yukihiro Shimizu; Masami Minemura; Takashi Tsukishiro; Yoshirou Kashii; Megumi M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB

Serum CA 125 level as a predictor of per

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-YS Chung; Yasuyuki Kato; Yoshito Yamashita; Kiyoshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. Prediction of peritoneal dissemination is very difficult using current diagnostic tools such as computed tomography, ultrasonography, or various tumor markers. The predictive value of serum CA 125 levels for peritoneal metastasis from gastric carcinoma was studied. ## METHODS. Th

Changes in tumor marker levels as a pred

Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-Y. S. Chung; Kazuya Muguruma; Yoshito Yamashita; Th 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

## BACKGROUND. Evaluating chemotherapeutic effect in patients with gastric carcinoma sometimes is difficult. The authors investigated whether changes in the serum levels of three tumor markers can be used to predict the clinical outcome after chemotherapy. ## METHODS. Thirty patients with advance

Low serum alpha-fetoprotein level in pat

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-fu and interferon-alpha-2b

✍ Yehuda Z. Patt; Richard Pazdur; Ruth Smith; Bernard Levin; Mark Roh; Boris Yoffe 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 854 KB

Serum ferritin as a tumor marker in pati

Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck

✍ Peter E. Maxim; Robert W. Veltri 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB